CATALOGO DEI PRODOTTI DELLA RICERCA

FERDEGHINI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.274
EU - Europa 5.535
AS - Asia 4.116
SA - Sud America 543
AF - Africa 44
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 18.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.202
SG - Singapore 1.864
RU - Federazione Russa 1.649
GB - Regno Unito 1.350
CN - Cina 1.334
FI - Finlandia 464
FR - Francia 450
DE - Germania 441
BR - Brasile 440
HK - Hong Kong 400
IE - Irlanda 343
SE - Svezia 315
VN - Vietnam 236
IT - Italia 200
UA - Ucraina 169
KR - Corea 62
IN - India 42
CA - Canada 37
AR - Argentina 36
TR - Turchia 34
ES - Italia 27
MX - Messico 25
BD - Bangladesh 24
BE - Belgio 22
ID - Indonesia 20
JP - Giappone 20
EC - Ecuador 19
PL - Polonia 19
ZA - Sudafrica 17
AT - Austria 15
NL - Olanda 14
CO - Colombia 13
PK - Pakistan 13
IQ - Iraq 12
AU - Australia 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
EG - Egitto 8
MA - Marocco 8
PY - Paraguay 7
CL - Cile 6
DK - Danimarca 6
EU - Europa 6
LT - Lituania 6
NP - Nepal 6
KZ - Kazakistan 5
RO - Romania 5
UY - Uruguay 5
UZ - Uzbekistan 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
HR - Croazia 4
HU - Ungheria 4
KE - Kenya 4
MY - Malesia 4
PE - Perù 4
PS - Palestinian Territory 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
IL - Israele 3
TH - Thailandia 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
LB - Libano 2
LI - Liechtenstein 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SI - Slovenia 2
TN - Tunisia 2
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CU - Cuba 1
DJ - Gibuti 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
Totale 18.530
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.639
Southend 1.106
Chandler 1.036
Woodbridge 844
Singapore 828
Ann Arbor 589
Dallas 566
Ashburn 440
Moscow 434
Houston 412
Hong Kong 396
Dublin 340
Wilmington 188
Lawrence 184
Princeton 184
Nanjing 143
Beijing 131
Sindelfingen 131
Los Angeles 125
New York 123
Boardman 111
Buffalo 98
Helsinki 92
Jinan 90
Shenyang 88
Hebei 85
Ho Chi Minh City 70
Tianjin 70
The Dalles 64
Philadelphia 59
Changsha 55
Verona 47
Nanchang 46
Detroit 45
Columbus 42
Hanoi 42
Hangzhou 39
Milan 39
São Paulo 38
Haikou 37
Jiaxing 37
Zhengzhou 37
Dong Ket 36
Norwalk 35
Ningbo 34
Munich 33
Santa Clara 33
Guangzhou 27
Redondo Beach 25
Falls Church 24
Chicago 23
Brussels 22
Taizhou 22
Washington 21
Bologna 20
San Francisco 20
Tokyo 19
Auburn Hills 17
Lanzhou 17
Toronto 17
Taiyuan 16
Warsaw 16
Dearborn 15
Lancaster 15
Tappahannock 15
Brooklyn 14
Chennai 14
Rio de Janeiro 14
Seattle 14
Stockholm 14
Düsseldorf 13
Turku 13
Atlanta 12
London 12
Phoenix 11
Da Nang 10
Montreal 10
Redwood City 10
Johannesburg 9
Seoul 9
Vienna 9
Boston 8
Fuzhou 8
Manchester 8
Orem 8
Poplar 8
San Diego 8
Shanghai 8
Biên Hòa 7
Bắc Ninh 7
Charlotte 7
Curitiba 7
Denver 7
Frankfurt am Main 7
Guayaquil 7
Jakarta 7
Kent 7
Secaucus 7
Shenzhen 7
Vigo 7
Totale 12.020
Salva come PNG Salva come JPEG
Nome #
[111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas 216
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 208
Gated reconstruction in 18FDG PET-CT quantitative imaging: impact on SUV estimation in lung tumors 186
First human Cerenkography. 179
SU-E-J-168: 4D-PET for Target Volume Delineation in Respiratory-Gated Radiation Therapy. 178
A mathematical model of thyroid mass reduction after radioiodine therapy of Graves’ disease 175
Espressione di Claudina-1 e 7 nel carcinoma papillare della tiroide con comportamento clinico aggressivo 173
Humanization of care in pediatrics and built-in psychological support in nuclear medicine [Umanizzazione delle cure in età pediatrica e assistenza psicologica integrata in Medicina nucleare] 171
Role of dual-point FDG PET/CT in prone position and fused PET/MR; correlation with biologic prognostic parameters in breast cancer 159
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 154
rhTSH-Stimulated Postsurgical Thyroid Remnant Ablation in Differentiated Thyroid Cancer: 1.85 vs 3.7 GBq I-131 Activity 154
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. 153
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 148
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal. 147
Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. 147
Valutazione comparativa dell'acquisizione volumetrica tiroidea con ecografia convenzionale B-Mode (US) ed ecografia volumetrica (VUS) 147
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma 142
[Primary empty sella syndrome. Clinical and radiological study, and evaluation of pituitary function] 141
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours 140
Acute suppression of parathyroid activity during hemofiltration 139
A new luminescence immunoassay for thyrotropin using coated tubes: evaluation and comparison with immunoradiometric assay 138
RET mutation and increased angiogenesis in medullary thyroid carcinomas 138
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma 137
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology 137
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 136
A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions 136
Optimized PET Imaging for 4D Treatment Planning in Radiotherapy: the Virtual 4D PET Strategy 133
Age and Gender Substantially Influence the Relationship Between Thyroid Status and the Lipoprotein Profile: Results from a Large Cross-Sectional Study. 132
Analytical and clinical assessment of a commercial kit for the simultaneous determination of free thyroxine and thyrotropin 130
[Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer] 130
[Bromocriptine therapy from the 2d month of pregnancy induces regression of neuro-ophthalmologic complications caused by macroprolactimona] 130
[Growth factors and oncogenes in development and carcinogenesis. Role of the epidermal growth factor system] 124
Lazaroid U-74389F attenuates phorbol ester-induced lung injury in rabbits 122
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between rhTSH stimulation and prolonged levothyroxine withdrawal. 117
[Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary] 116
Comparison of plasma and urinary methods for the direct measurement of the thyroxine to 3,5,3' - triiodothyronine conversion rate in man 116
A computer program for customized recommendations to radioiodine-treated patients [Studio e realizzazione di un programma computerizzato per prescrizioni personalizzate a pazienti iodiotrattati in dimissione] 116
Relation of fetal growth to maternal responses to oral glucose tolerance test throughout gestation 115
CAM26, CAM29 and mucin-like carcinoma associated antigen in epithelial ovarian cancer 113
Blood markers of early and late airway responses to allergen in asthmatic subjects. Relationship with functional findings 113
[Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary] 112
Clinical validation of the new ELSA-CA 125 II assay: report of a European multicentre evaluation 110
The relationship between maternal relaxation and plasma beta-endorphin levels during parturition 110
Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. 110
Tumor-associated trypsin inhibitor (TATI) and renal function 109
Serum interleukin-6 levels in uterine malignancies. Preliminary data 109
Functional Imaging and Peptide Receptor Radionuclide Therapy 109
Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix 108
Serum tumour-associated trypsin inhibitor (TATI) and renal function 108
Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical training 108
Hypothalamo-pituitary function in four cases of true precocious puberty 108
Can insulin action induce myocardial texture alterations in essential hypertension? 108
Plasma leptin levels in newborns from normal and diabetic mothers. 108
Autonomous thyroid nodule and percutaneous ethanol injection [letter] [see comments] 107
Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer 106
Effects of the ablation of the submaxillary gland on the rat testis 106
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancer 106
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer 105
Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancer 105
[Comparison of serum determinations of CA125, CA15-3 and CA50 in the preoperative evaluation of adnexal tumors] 104
Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid). 104
Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders 103
T-helper 1 and 2 activation with fresh or cultured allo- or xenoislets 103
Assessment of tumor-associated trypsin inhibitor (TATI) as a marker of renal function. 103
Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis. 103
Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses 102
Circulating levels of IGF-I in patients with chronic uremia on conservative dietary treatment. 102
Comparison between serum CA 125 and CA 19-9 assays and tissular OC 125 and 1116NS 19-9 reactivity in malignant and benign ovarian tumors 101
Relationship between the circulating levels of adenohypophyseal hormones in blood and in cerebrospinal fluid 101
Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma 100
Hyperprolactinemic amenorrhea induced by an intrasellar epithelial cyst 100
Radioimmunoassay of unconjugated and total serum estetrol using a 125I-iodinated tracer 100
Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia. 100
External quality control survey for alpha-fetoprotein assay 99
Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome. 99
Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine? 99
Soluble interleukin-2 receptor release during culture of human lymphocytes with human, porcine, or bovine islets and the effect of culture and cryopreservation 98
Anticlastogenic Effect of Ginkgo biloba Extract in Graves' Disease Patients Receiving Radioiodine Therapy 98
Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia 97
Anomalous between-laboratory variability in a collaborative study of carcinoembryonic antigen immunoassay [letter] 97
Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancer 96
Determination of serum levels of different cytokeratins in patients with uterine malignancies 96
Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations 96
The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinoma 96
Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer. 96
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma 95
Endothelin-1 release from atherosclerotic plaque after percutaneous transluminal coronary angioplasty in stable angina pectoris and single-vessel coronary artery disease. 95
Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects. 95
Comet assay on children's leukocytes 8 years after the Chernobyl disaster 94
Serum soluble interleukin-2 receptor assay in epithelial ovarian cancer 94
High-performance liquid chromatographic separation of iodoamino acids for tracer turnover studies of thyroid hormones in vivo 94
Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women 93
Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin 93
Human placental lactogen (hPL) deficiency in a normal pregnancy 92
Severe leukopenia and mild thrombocytopenia after chronic bromocriptine (CB-154) administration 92
Radioimmunoassay of free cortisol with antiserum-coated tubes and 125I-labeled cortisol [letter] 91
Preoperative evaluation of CA 125 and CA 19-9 serum levels in patients with ovarian masses 90
Total and free (dialyzable) cortisol assay in plasma: comparison of two RIA methods involving the use of antibody-coated test tubes 90
Oxidative and genotoxic damage after radio-iodine therapy of Graves' hyperthyroidism 90
Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer. 90
Totale 11.819
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.136
article - articoli 61.841
book - libri 0
conference - conferenze 2.267
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.028
Totale 130.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.055 0 0 0 0 221 206 10 171 162 5 201 79
2021/2022955 38 121 7 37 35 24 13 81 81 49 127 342
2022/20232.784 228 176 256 505 351 599 15 238 274 17 85 40
2023/20241.097 79 143 109 257 86 136 24 35 7 13 115 93
2024/20252.780 250 192 31 497 158 39 30 165 506 168 228 516
2025/20264.150 683 459 659 1.060 1.289 0 0 0 0 0 0 0
Totale 18.577